A detailed history of Spirepoint Private Client, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Spirepoint Private Client, LLC holds 69,638 shares of BSX stock, worth $6.37 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
69,638
Previous 68,295 1.97%
Holding current value
$6.37 Million
Previous $5.26 Billion 10.96%
% of portfolio
0.77%
Previous 0.75%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$72.96 - $84.0 $97,985 - $112,812
1,343 Added 1.97%
69,638 $5.84 Billion
Q2 2024

Aug 08, 2024

BUY
$67.33 - $77.71 $68,272 - $78,797
1,014 Added 1.51%
68,295 $5.26 Billion
Q1 2024

May 10, 2024

BUY
$57.6 - $68.62 $3.88 Million - $4.62 Million
67,281 New
67,281 $4.61 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Spirepoint Private Client, LLC Portfolio

Follow Spirepoint Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spirepoint Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spirepoint Private Client, LLC with notifications on news.